PHASE 2 CLINICAL EVALUATION OF PRECLINICALLY DEFINED BIOMARKERS FOR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) TYROSINE KINASE INHIBITOR (TKI) TIVOZANIB IN RENAL CELL CARCINOMA (RCC)

被引：0
|
作者：
Hutson, T. [1 ]
Rathmell, W. K. [2 ]
Feng, B. [3 ]
Robinson, M. O. [3 ]
Gyuris, J. [3 ]
Lin, J. [3 ]
Choueiri, T. [4 ]
机构：
[1] Baylor Sammons Canc Ctr, GU Oncol Program, Dallas, TX USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, North Carolina Canc Hosp, Chapel Hill, NC 27599 USA
[3] AVEO Oncol, Clin Res, Cambridge, MA USA
[4] Dana Farber Canc Inst, Div Solid Tumor Oncol, Boston, MA 02115 USA
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu326.66
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233P
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Comparison of radiographic characteristics of renal cell carcinoma (RCC) brain metastases treated with vascular endothelial growth factor (VEGF) - directed therapies or radiotherapy
    Goud, Ajay
    DeWalt, Kara
    Carmichael, Courtney
    Hsu, Joann
    Pinnamaneni, Manasvi
    Pal, Sumanta Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [32] Tivozanib pharmacokinetic (PK)/pharmacodynamic (PD) analysis of blood pressure and soluble vascular endothelial growth factor receptor 2 (sVEGFR2) in patients with advanced renal cell carcinoma (RCC)
    Nosov, D. A.
    Motzer, R. J.
    Loewy, J.
    Hodge, L.
    Esteves, B.
    Berkenblit, A.
    Yin, W.
    Dykstra, K.
    Hutson, T. E.
    Cotreau, M. M.
    BJU INTERNATIONAL, 2012, 110 : 5 - 5
  • [33] Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro
    Juengel, Eva
    Engler, Johanna
    Mickuckyte, Ausra
    Jones, Jon
    Hudak, Lukasz
    Jonas, Dietger
    Blaheta, Roman A.
    BJU INTERNATIONAL, 2010, 105 (04) : 549 - 557
  • [34] SERUM THYMIDINE KINASE AND VASCULAR EN DOTHELIAL GROWTH FACTOR (VEGF) IN RENAL CELL CARCINOMA
    Nisman, B.
    Nechushtan, H.
    Yutkin, V.
    Peretz, T.
    Gronowitz, S.
    Pode, D.
    TUMOR BIOLOGY, 2010, 31 : S64 - S65
  • [35] A phase II trial of perifosine in patients with advanced renal cell carcinoma (RCC) who have failed tyrosine kinase inhibitors (TKI)
    Cho, D. C.
    Figlin, R. A.
    Flaherty, K. T.
    Michaelson, D.
    Sosman, J. A.
    Ghebremichael, M.
    Bowers, M. E.
    Mier, J. W.
    Atkins, M. B.
    McDermott, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma - Comment
    OBrien, T
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (05): : 687 - 687
  • [37] Efficacy of adjuvant vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (VEGFRi) in renal-cell carcinoma (RCC): Systematic review and meta-analysis
    Botrel, Tobias Engel Ayer
    Paladini, Luciano
    Clark, Otavio
    Clark, Luciana
    Rosa, Bruna Pegoretti
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Acquired Drug Resistance to Vascular Endothelial Growth Factor Receptor 2 Tyrosine Kinase Inhibitor in Human Vascular Endothelial Cells
    Arao, Tokuzo
    Matsumoto, Kazuko
    Furuta, Kazuyuki
    Kudo, Kanae
    Kaneda, Hiroyasu
    Nagai, Tomoyuki
    Sakai, Kazuko
    Fujita, Yoshihiko
    Tamura, Daisuke
    Aomatsu, Keiichi
    Koizumi, Fumiaki
    Nishio, Kazuto
    ANTICANCER RESEARCH, 2011, 31 (09) : 2787 - 2796
  • [39] TIVOZANIB PHARMACOKINETIC (PK)/PHARMACODYNAMIC (PD) ANALYSIS OF BLOOD PRESSURE (BP) AND SOLUBLE VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (SVEGFR2) IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)
    Nosov, D.
    Motzer, R. J.
    Loewy, J.
    Hodge, L.
    Esteves, B.
    Berkenblit, A.
    Yin, W.
    Dykstra, K.
    Hutson, T. E.
    Cotreau, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 263 - 263
  • [40] MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS VERSUS VASCULAR ENDOTHELIAL GROWTH FACTOR TYROSINE KINASE INHIBITORS (VEGF TKI) AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AFTER FAILURE OF FIRST-LINE VEGF TKI: SINGLE CENTER RETROSPECTIVE ANALYSIS
    Lee, J. -L.
    Park, K.
    Park, I.
    Park, S.
    Ahn, Y.
    Ahn, J. -H.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 141 - 141
12345